<http://schema.org/description>
"The drug combination indacaterol/glycopyrronium (trade name: Ultibro Breezhaler, Xoterna Breezhaler) has been approved since September 2013 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this drug combination offers an added benefit over the appropriate comparator therapy."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2014-02-minor-added-benefit-indacaterolglycopyrronium-copd.html>